Form 8-K CYTORI THERAPEUTICS, For: Mar 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Wall St set to open higher as jobs data dampens rate hike odds, yields fall
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
Cytori Therapeutics (CYTX) Files $40M Common Shelf
March 16, 2015 5:04 PM EDTCytori Therapeutics (NASDAQ: CYTX) filed to sell up to $40 million worth of its Common Stock.
... MoreCytori Therapeutics (CYTX) Reports In-Line Q4 EPS
March 12, 2015 4:35 PM EDTCytori Therapeutics (NASDAQ: CYTX) reported Q4 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $2.47 million versus the consensus estimate of $3.1 million.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
... MoreCytori Therapeutics (CYTX) Regains Nasdaq Listing Compliance
March 12, 2015 2:42 PM EDTOn March 12, 2015, Cytori Therapeutics (NASDAQ: CYTX) received written notification from The NASDAQ Stock Market LLC (NASDAQ) that it has regained compliance with the Nasdaq Stock Market Listing Rule 5450(a)(1) concerning the Companys closing bid price. The Company previously received written notification from NASDAQ indicating... More
